17 August 2026 | 6:45AM BST Equity Research Sandoz Group AG (SDZ.S): Further expands best-in-class pipeline with collaboration with Henlius for up to 10 biosimilars This morning (Aug 17), Sandoz announced a strategic collaboration with Shanghai Henlius Biotech (covered by Ziyi Chen) on up to 10 biosimilars (incl. monoclonal antibodies and/or antibody-drug conjugates), further expanding its best-in-class biosimilar pipeline from 36 to 39 (with a potential to increase to up to 46). The initial agreement cover ...